ARTICLE | Company News
Transgenomic, Dana-Farber Cancer Institute deal
March 21, 2011 7:00 AM UTC
The partners expanded a 2009 deal under which Transgenomic received exclusive, worldwide rights to commercialize the institute's COLD-PCR high-sensitivity mutation detection technology for Sanger seq...